LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholie SP, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, Anglaret X, Laurent C
Download
Download
Abstract
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.
Countries
BeninBurkina FasoCambodiaCameroonCôte d'IvoireLaosSenegal
Subject Area
HIV/AIDS
DOI
10.1097/QAI.0b013e3182821821
Published Date
15-Apr-2013
PubMed ID
23274931
Languages
English
Journal
Journal of Acquired Immune Deficiency Syndromes (1999)
Volume / Issue / Pages
Volume 62, Issue 5
Issue Date
15-Apr-2013
Dimensions Badge